CMS accepted a request from Edwards Lifesciences for a new coverage determination (NCD) for transcatheter aortic valve ...

Edwards pushes CMS to expand Medicare TAVR coverage as agency opens public comment period through January 2026 for decision.

The global, multibillion-dollar transcatheter heart valves market will grow at an 8.4% CAGR over the rest of the 2020s, ...

Edwards Lifesciences Corp., of Irvine, Calif., petitioned the Centers for Medicare & Medicaid Services to revise the Medicare ...

PLYMOUTH MEETING, Pa. (WPVI) -- The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to ...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace your aortic valve. The aortic valve controls blood flow from your heart to your aorta, the main artery that ...

The global Transcatheter Aortic Valve Replacement (TAVR) Market is valued at USD 6.8 Billion in 2024 and is projected to reach USD 14.06 Billion by 2035, growing at a CAGR of 6.9% between 2025 and ...

SAN FRANCISCO, CA – In a clinical trial, a second-generation transcatheter aortic valve demonstrated low rates of complications that are sometimes seen in transcatheter aortic valve replacement (TAVR) ...

Transcatheter aortic valve replacement, or TAVR, is a minimally invasive heart procedure that replaces a thickened aortic valve that can't fully open (aortic stenosis). The procedure restores proper ...

DUBLIN--(BUSINESS WIRE)--The "Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Size, Share & Trends Analysis Report By Procedure (Transapical ...

IRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial transcatheter aortic valve replacement (TAVR) system for the treatment of aortic ...

NEW YORK, Sept. 8, 2025 /PRNewswire/ -- The rising prevalence of aortic stenosis, growing adoption of minimally invasive heart valve procedures, and increasing approvals for lower-risk patients are ...